|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.43 USD | -0.75% |
|
-3.07% | +31.59% |
| 07-29 | Deutsche Bank Adjusts CVS Health Price Target to $116 From $92 | MT |
| 07-29 | X, World Federation of Advertisers settle litigation over GARM dispute | RE |
| Market Cap | 133B 116B 108B 98.85B 187B 12,710B 190B 1,267B 498B 6,330B 500B 489B 20,973B | P/E 2026 * |
16.7x | P/E 2027 * | 14.5x |
|---|---|---|---|---|---|
| Enterprise Value | 189B 164B 153B 140B 265B 18,030B 269B 1,797B 706B 8,979B 710B 694B 29,750B | EV / Sales 2026 * |
0.46x | EV / Sales 2027 * | 0.43x |
| Free-Float |
71.2% | Yield 2026 * |
2.54% | Yield 2027 * | 2.62% |
Last Transcript: CVS Health Corporation
| 1 day | -0.75% | ||
| 1 week | -3.07% | ||
| 1 month | +0.95% | ||
| 3 months | +25.38% | ||
| 6 months | +40.14% | ||
| Current year | +31.59% |
| 1 week | 103.01 |  | 110 |
| 1 month | 101.78 | | 110.68 |
| Current year | 69.51 | | 110.68 |
| 1 year | 61.35 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
Ali Keshavarz
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/14/26 | Free | Director | 1,737 | 0.0001% | ||
| 2/28/26 | Tax | Executive/Senior Manager | 7,886 | 0.0006% | ||
| 2/28/26 | Tax | Chief Executive Officer | 1,944 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.75% | -3.07% | +68.16% | +39.82% | 133B | |
| +1.72% | +5.34% | +13.73% | +47.57% | 87.16B | |
| -0.80% | +1.64% | +6.05% | +56.05% | 28.85B | |
| -0.55% | +2.26% | +39.19% | +72.33% | 25.72B | |
| -0.63% | +9.25% | -10.37% | -18.69% | 21.9B | |
| +0.81% | +9.25% | +57.97% | +240.93% | 20.51B | |
| +0.51% | +1.98% | +71.04% | +135.41% | 15.41B | |
| +0.64% | +3.77% | +6.58% | -3.78% | 14.98B | |
| +0.36% | +2.73% | -0.07% | -5.87% | 13.55B | |
| -2.48% | +1.58% | -11.68% | +85.10% | 11.2B | |
| Average | -0.12% | +3.47% | +24.06% | +64.89% | 37.25B | |
| Weighted average by Cap. | +0.03% | +1.87% | +36.20% | +54.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 409B 355B 331B 304B 574B 39,055B 583B 3,893B 1,529B 19,451B 1,538B 1,504B 64,443B | 427B 370B 345B 317B 598B 40,705B 608B 4,058B 1,593B 20,272B 1,602B 1,567B 67,165B |
| Net income | 8.04B 6.98B 6.5B 5.97B 11.28B 767B 11.46B 76.5B 30.04B 382B 30.21B 29.55B 1,266B | 9.35B 8.11B 7.55B 6.93B 13.1B 892B 13.31B 88.88B 34.9B 444B 35.1B 34.33B 1,471B |
| Net Debt | 55.76B 48.37B 45.02B 41.37B 78.17B 5,319B 79.43B 530B 208B 2,649B 209B 205B 8,777B | 52.15B 45.24B 42.11B 38.69B 73.1B 4,975B 74.28B 496B 195B 2,478B 196B 192B 8,208B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$104.43 | -0.75% | 7,081,286 |
| 26-07-30 | US$105.22 | -0.66% | 7,738,249 |
| 26-07-29 | US$105.92 | -3.13% | 7,718,243 |
| 26-07-28 | US$109.34 | +2.12% | 6,682,269 |
| 26-07-27 | US$107.07 | -0.62% | 7,857,618 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
